Soleno Therapeutics, Inc. (SLNO) Misses Q3 EPS by 122c

Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q3 EPS of ($1.83), $1.22 worse than the analyst estimate of ($0.61).

For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Axis Capital Limited Upgrades Tata Consultancy Services Ltd. (TCS:IN) to Buy (1)
• EssilorLuxottica SA (EL:FP) (ESLOY) PT Lowered to EUR181 at Deutsche Bank